Mirae Asset Healthcare Fund Regular Growth is a Sector - Healthcare mutual fund scheme from Mirae Asset Investment Managers (India) Private Limited. The fund was launched on 2 June 2018 and is managed by Tanmay Mehta and Vrijesh Kasera. As of 15 October 2026, the fund has an AUM of ₹3,494.44 Cr and its latest NAV is ₹43.91. The fund has a Very High Risk risk rating.
The fund allows minimum SIP of ₹99 and lumpsum investment starting from ₹5,000.
The fund primarily invests in Healthcare and Basic Materials and its top holdings include Sun Pharmaceuticals Industries Ltd, Divi's Laboratories Ltd, Torrent Pharmaceuticals Ltd, J.B. Chemicals & Pharmaceuticals Ltd, and Apollo Hospitals Enterprise Ltd. The fund has delivered 13.5% returns over the last 1 year, 19.5% annualised returns over 3 years, 13.0% annualised returns over 5 years, and 19.4% annualised returns since inception.
Mirae Asset Healthcare Fund Regular Growth may be suitable for investors looking for Sector - Healthcare and who are comfortable with Very High Risk risk.






